ARTICLE | Company News
Allergan, Inspire dry eye deal
June 27, 2001 7:00 AM UTC
AGN received exclusive worldwide rights, except in Japan, to develop and commercialize ISPH's INS365 Ophthalmic, which is in Phase III testing for dry eye disease. ISPH will receive up to $39 million ...